Zepp Health Corporation ('Zepp' or the 'Company') (NYSE: ZEPP) today announced its unaudited financial results for the fourth quarter of 2024.

Explore why Micron's recent price dip might not signal a buying opportunity. Learn about emerging catalysts impacting MU's ...

January 2025 - Cingulate completed its final FDA-required study, a food effect study utilizing a single 50-mg dose of ...

Pat Clay, herbicide product development manager for Valent USA, talks with Ohio Ag Net’s Joe Everett about a new product ...

Google has confirmed it will move development of the Android OS to behind closed doors. Here's why it's doing it.

Tops on Ivan Espinosa’s to-do list will be to seek collaborations with companies to help Nissan develop EVs and refresh its ...

Nissan plans to dramatically cut its car development time to boost its competitiveness, the struggling automaker's incoming ...

The integration of AI and cloud technologies is transforming pharmaceutical manufacturing regulations, focusing on safety, efficiency, and global harmonization.

In a March 24 note to investors, UBS analyst Timothy Arcuri wrote that Intel’s near-term plan under the leadership of newly ...

As of the end of March 2024, the company had a net cash position of over NZD 400 million.

CR Land's net debt/equity ratio is low among state-owned developers at around 32%, despite its heavier emphasis on investment properties. Although the housing price contraction in 2022-24 has squeezed ...

As Nissan navigates a challenging period marked by declining sales and mounting competition, incoming CEO Ivan Espinosa is ...